Target intelligence / Profile preview

Fc gamma receptor-bearing immune cell activation via ADCC (ADCC)

Target
ADCC
Molecular classification
Immune cell activation pathway, Cellular cytotoxicity mechanism
01

Overview

Fc gamma receptor-bearing immune cell activation via antibody-dependent cellular cytotoxicity (ADCC) is a key effector mechanism by which IgG antibodies mediate the destruction of target cells. This process involves the binding of IgG antibodies to target cells, followed by the engagement of FcγRs on immune cells (e.g., NK cells, macrophages) with the Fc region of the bound antibodies. This interaction triggers activation of the immune cell, leading to the release of cytotoxic granules or phagocytosis of the target cell. The efficacy of ADCC is influenced by factors such as FcγR expression levels, receptor polymorphisms, and IgG subclass.

Other names
Antibody-dependent cellular cytotoxicityFcγR-mediated cytotoxicity
02

Mechanism of action

Cross-linking of activating FcγRs on effector immune cells by IgG-coated target cells, leading to degranulation and release of cytotoxic molecules (perforin, granzymes) or phagocytosis.

03

Biological functions

Immune responseCell-mediated cytotoxicityTumor cell killingPathogen clearanceInflammatory cytokine productionAntigen presentation enhancement
04

Disease associations

CancerInfectionAutoimmune diseasesInflammatory diseases
05

Safety considerations

Cytokine release syndromeOff-target cytotoxicityAutoimmune reactionsInfusion reactions
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

FcγRIIIa (CD16A) expression levelsFcγR polymorphisms (e.g., FcγRIIIa-158V/F)IgG subclass levelsNK cell activityADCC activity

Beyond the preview

Go deeper on Fc gamma receptor-bearing immune cell activation via ADCC (ADCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc gamma receptor-bearing immune cell activation via ADCC (ADCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call